S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

KZIA Kazia Therapeutics Ltd

0.8023

0.0123 (1.56%)

Mar 06 2025 - Closed

Delayed by 15 minutes

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

null

Kazia Therapeutics (NASDAQ:KZIA)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Kazia Therapeutics Charts.

Kazia Therapeutics (NASDAQ:KZIA)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Kazia Therapeutics Charts.

Kazia Therapeutics Ltd News

Form 424B3 - Prospectus [Rule 424(b)(3)]
Friday 21 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Thursday 20 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Thursday 20 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 20 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Kazia Therapeutics and the Hebrew University of Jerusalem Receives a Grant from The Michael J. Fox Foundation to Evaluate the Therapeutic Potential of Paxalisib as a Treatment for Parkinson's Disease
Thursday 20 February 2025 (2 weeks ago) • PR Newswire (US)

Form EFFECT - Notice of Effectiveness
Wednesday 5 February 2025 (4 weeks ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Wednesday 5 February 2025 (4 weeks ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 3 February 2025 (1 month ago) • Edgar (US Regulatory)

Form F-1 - Registration statement for certain foreign private issuers
Thursday 30 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Thursday 30 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Thursday 30 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 30 January 2025 (1 month ago) • Edgar (US Regulatory)

More Kazia Therapeutics Ltd News Articles

Tonix Pharmaceuticals

Mullen Automotive

Accredited Solutions (PK)

RespireRx Pharmaceuticals (CE)

Kraig Biocraft Laborator... (QB)

TPT Global Tech (PK)

Impact Fusion (PK)

Asia Broadband (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions